Moderna

Stories 21 - 40 | << Prev   Next >>

'Lot of Infections' From Omicron After 4th Dose: Trial

In preliminary study from Israel, the first of its kind, antibodies rise after 2nd booster, infections persist

(Newser) - Preliminary results are in on a clinical trial testing the efficacy of a fourth COVID shot, the world's first, and when it comes to omicron, that booster isn't doing the job researchers had hoped for. The Times of Israel reports that, in a study that began last month...

Scientists Announce Big Find on Multiple Sclerosis
Scientists Announce Big Find
on Multiple Sclerosis
NEW STUDY
Jan 14, 2022 7:35 AM CST

Scientists Announce Big Find on Multiple Sclerosis

Findings 'strongly suggest' Epstein-Barr virus is 'a cause and not a consequence of MS'

(Newser) - Researchers say more treatments for multiple sclerosis may be possible after finding a likely "initial trigger" of the auto immune disease. It's unknown what exactly causes MS, a condition affecting 2.8 million people in which immune system cells attack the protective coating on nerve fibers, though some...

Good News on Moderna Booster
Good
News on
Moderna
Booster
Dec 20, 2021 8:33 AM CST

Good News on Moderna Booster

Early lab results suggests third shot provides significant protection against omicron

(Newser) - Lab results from Moderna add to health officials' chorus on omicron: Get a booster. The company said Monday that preliminary results suggests a third shot of its vaccine provides significant protection against the new variant. The usual half-dose booster raised antibody levels 37-fold, while a full-dose booster—typically given to...

CDC Panel Backs Other Vaccines Over J&amp;J&#39;s
CDC:
Get Pfizer or
Moderna,
Not J&J
UPDATED
Dec 17, 2021 2:51 AM CST

CDC: Get Pfizer or Moderna, Not J&J

CDC makes official new recommendation

(Newser) - Update: The CDC is now officially taking the stance that that "mRNA vaccines are preferred over [Johnson & Johnson's] Janssen COVID-19 vaccine for the prevention of COVID-19 for those 18 years of age and over." Within hours of a panel making that recommendation, the CDC director accepted...

Moderna CEO Predicts 'Material Drop' in Vaccine Effectiveness

Dow futures sink on Omicron news

(Newser) - Drugmakers and health officials say we won't know for a few weeks just how bad the omicron variant will be, particularly in regard to the current vaccines. In the meantime, sentiment is seesawing, as reflected in world financial markets. Friday was grim , Monday rebounded , and now Tuesday is shifting...

Moderna Jumps 11.8% as It Tests Vaccine Against Variant

Markets recover ground after Friday's big drop

(Newser) - The stock market steadied itself Monday following a slide last week brought on by the newest coronavirus variant. Investors are waiting for more clues about just how much damage the new strain may do to the economy. The S&P 500 recovered more than half its drop from Friday. Bond...

CDC Panel Backs Boosters, Especially for Ages 50 and Up

After one more step, shots could be made available to all adults this weekend

(Newser) - Update: This file has been updated to reflect the recommendation of CDC advisers. The US government on Friday moved to open up COVID-19 booster shots to all adults, expanding efforts to get ahead of rising coronavirus cases that experts fear could snowball into a winter surge as millions of Americans...

Maryland Man Pleads Guilty in COVID Vaccine Scam

Fake site set up to look just like Moderna's offered supposed doses for $30 a pop, feds say

(Newser) - Earlier this year, before COVID vaccines were readily available to eligible patients, a website suddenly popped up advertising Moderna doses for $30 each. That site turned out to be a fake, and now a Maryland man has owned up to his role in getting it up and running. The Baltimore ...

Moderna Touts Results of Vaccine for Children 6 to 11

Company is awaiting FDA approval of its product for teenagers

(Newser) - Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer joins Pfizer in moving toward expanding shots to children. Moderna hasn't received the go-ahead to offer its vaccine to teens but is studying lower doses...

Booster Shots Are Expected to Start Going in Arms Today

CDC, Walensky gave final approval Thursday night

(Newser) - Update: An advisory panel unanimously recommended to the Centers for Disease Control and Prevention on Thursday that coronavirus vaccine booster shots be approved. Tens of millions of people would be eligible for the doses, which the FDA backed the day before, the Washington Post reports. (There's an explainer on...

J&J Could've Been 2 Shots All Along, Fauci Says

Booster recipients probably will be able to mix brands

(Newser) - In hindsight, the Johnson & Johnson coronavirus vaccine probably should have been two shots from the start, as other vaccines are, Dr. Anthony Fauci said Sunday. Asked on ABC's This Week whether people who received the company's single dose should be alarmed because an FDA advisory panel has...

FDA to Study Possible Moderna Side Effect

Decision will delay approval for 12- to 17-year-olds

(Newser) - With several European nations rethinking their endorsements of giving the Moderna vaccine to young people, the FDA will study a potential side effect longer before deciding on approval. The issue is myocarditis, a rare inflammatory heart condition, the Wall Street Journal reports. Finland, Sweden, Denmark, and Norway have called for...

FDA Panel Recommends Moderna Booster Shots

Advisers say seniors and people at risk should get another half-dose

(Newser) - US health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus, reports the AP . The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors and adults with...

FDA Report Is Inconclusive on Johnson & Johnson Booster

Outside advisers are meeting this week to consider approval and interval

(Newser) - It's not clear yet whether people who received the one-shot Johnson & Johnson coronavirus vaccine will be cleared to get a booster shot or will be told to switch brands. A Food and Drug Administration staff report released Wednesday said that there's evidence the J&J booster strengthened...

BioNTech, Pfizer Stocks Jump After FDA Approval
BioNTech, Pfizer Stocks
Jump After FDA Approval
MARKETS
Aug 23, 2021 4:03 PM CDT

BioNTech, Pfizer Stocks Jump After FDA Approval

Nasdaq hits new record high

(Newser) - Stocks closed higher on Wall Street Monday, allowing the S&P 500 to regain the ground it lost last week and bringing it just shy of another record high. The benchmark index added 0.9%, driven by gains in a broad range of technology, financial, and communication stocks. The tech-heavy...

Pfizer, Moderna to Add Children to Trials

FDA wants more data on myocarditis

(Newser) - The availability of coronavirus vaccines for younger children could be delayed, after the Food and Drug Administration asked Pfizer and Moderna to expand its trials. The agency wants to know if a rare inflammation of the heart muscle that has surfaced in young adults would more of a problem in...

Pfizer, Moderna Recipients May Not Need Boosters
Pfizer, Moderna Recipients
May Not Need Boosters
new study
Jun 28, 2021 1:23 PM CDT

Pfizer, Moderna Recipients May Not Need Boosters

Study suggests the mRNA vaccines provide years of evolving protection from COVID

(Newser) - Anyone who received a double dose of either the Pfizer or Moderna vaccines may not need a booster shot anytime soon. A new study in Nature suggests that the mRNA vaccines provide years of protection—maybe even a lifetime of it, reports the New York Times . One big caveat: The...

Vaccine Cocktail Might Work: Researchers

Some countries recommend switching brands for the second dose

(Newser) - Can you mix and match two-dose COVID-19 vaccines? It's likely safe and effective, but researchers are still gathering data to be sure. The authorized COVID-19 shots around the world are all designed to stimulate your immune system to produce virus-fighting antibodies, though the way they do so varies, noted...

Vaccine May Be Ready for Youngest by Fall

Testing to include children 6 months to 12

(Newser) - Pfizer and Moderna are testing their coronavirus vaccines in children under 12, in a process that could have doses ready for US recipients as young as 6 months old by fall. Pfizer said Tuesday that it's starting its tests with children as young as 5 and will add younger...

Moderna Says Its Vaccine Works in Kids as Young as 12

It will submit trial data to FDA early next month

(Newser) - Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the US. With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in...

Stories 21 - 40 | << Prev   Next >>
Most Read on Newser